1. 1. Mary M Horgan, William G Powderly. Oral fungal infections. In: McGinnis MR, Anaissie EJ, Pfaller MA, editors. Pfaller's Clinical Mycology. Edinburgh: Churchill Livingstone, c2003, 1st ed:p446.
2. 2. Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK. MMWR Recommendations and Reports, Treating Oppurtunistic infections among HIV infected Adults and Adolescents. Recommendations from CDC.2004 Dec, 53 ; 1 -112.
3. 3. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV infected persons. J Acquire Immune defici Syndr 1994, 4: 770 -776.
4. 4. Dupont B, Denning DW, Marriot D, Sugar A, Vivani MA, Srisanthana T. Mycosis and AIDs patients. J Med Mycol. 1992, 32:19 -28.
5. 5. Calvet HM, Yeaman MR, Filler SG.Reversible fluconazole resistance in Candida albicans: a potential in vitro model. Antimicrob Agents Chemother. 1997, 41: 535 -539.